FDA’s Top Infectious Disease Official Adam Sherwat Set to Depart Agency in April.
admin The Food and Drug Administration official in charge of reviewing infectious disease products is leaving...
Health
Azalea Therapeutics and the Quest to Engineer CAR-T Cells Directly Within the Human Body.
The landscape of modern oncology was fundamentally shifted with the advent of CAR-T cell therapy,...
J&J wins approval for first-of-its-kind psoriasis pill
The approval of Icotyde comes at a pivotal time for the global pharmaceutical industry, particularly...
VC firm Dimension scouting out $700 million for new fund
The firm’s founders—Zavain Dar, Nan Li, and Adam Goulburn—represent a new guard of venture capitalists...
The Invisible Crisis: Why America’s Community Health Centers Are on the Brink of Collapse
Twenty years ago, during a walkthrough and shadowing session at a Federally Qualified Health Center...
A brain-computer interface allowed people with paralysis to type with their minds
In the study led by researchers from the Mass General Brigham Neuroscience Institute and Brown...
Structure Therapeutics reports significant weight loss from mid-stage GLP-1 pill
The weight loss figure reported by Structure Therapeutics is particularly striking when placed alongside the...
Trump Gains Public Trust on Drug Pricing as Biotech Industry Launches Counter-Offensive Against Proposed Caps.
As the second term of the Trump administration moves into its second year, a striking...
Epstein’s pal returns to biotech, Prasad’s FDA exit part deux, and more news from The Readout
The intersection of high-finance controversy, federal regulatory shifts, and groundbreaking oncological science has created a...
Invivyd Taps Epidemiologist Michael Mina as Chief Medical Officer to Steer Post-Pandemic Antibody Strategy.
In a move that signals a significant reinforcement of its clinical and strategic leadership, Invivyd,...
